VANGUARD GROUP INC 13D and 13G filings for Veracyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-02 2:12 pm Purchase | 2024-09-30 | 13G | Veracyte, Inc. VCYT | VANGUARD GROUP INC | 7,748,514 10.080% | 630,303 (+8.85%) | Filing |
| 2024-02-13 5:16 pm Purchase | 2023-12-29 | 13G | Veracyte, Inc. VCYT | VANGUARD GROUP INC | 7,118,211 9.750% | 265,554 (+3.88%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Veracyte, Inc. VCYT | VANGUARD GROUP INC | 6,852,657 9.550% | 257,313 (+3.90%) | Filing |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Veracyte, Inc. VCYT | VANGUARD GROUP INC | 6,595,344 9.280% | 2,338,174 (+54.92%) | Filing |
| 2021-02-10 11:57 am Purchase | 2020-12-31 | 13G | Veracyte, Inc. VCYT | VANGUARD GROUP INC | 4,257,170 7.350% | 1,588,676 (+59.53%) | Filing |